LivaNova (LIVN) Income from Discontinued Operations (2015 - 2020)
LivaNova's (LIVN) quarterly Income from Discontinued Operations came in at -$498000.0 in Q4 2020, down 366.31% year-over-year from $187000.0 in Q1 2020, and up 49.95% quarter-over-quarter from -$995000.0 in Q1 2020.
Powered by 
Analysis
LivaNova (LIVN) Income from Discontinued Operations (2015 - 2020) Analysis & Trends
LivaNova has disclosed Income from Discontinued Operations across 6 years of filings, most recently posting -$498000.0 for Q4 2020.
- In Q4 2020, Income from Discontinued Operations fell 366.31% year-over-year to -$498000.0; the TTM figure through Sep 2021 stood at -$498000.0 (up 38.37% YoY), while the FY2020 annual figure was -$1.5 million, down 509.04% from the prior year.
- Income from Discontinued Operations came in at -$498000.0 for Q4 2020 at LivaNova, up from -$995000.0 in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of $1.8 million in Q2 2017 to a low of -$80.2 million in Q4 2017.
- Average Income from Discontinued Operations over 5 years is -$9.8 million, with a median of -$1.5 million recorded in 2017.
- Year-over-year, Income from Discontinued Operations surged 148.12% in 2017 and slumped 366.31% in 2020.
- Over 5 years, Income from Discontinued Operations stood at -$23.5 million in 2016, then plunged by 241.51% to -$80.2 million in 2017, then jumped by 98.73% to -$1.0 million in 2018, then soared by 118.3% to $187000.0 in 2019, then tumbled by 366.31% to -$498000.0 in 2020.
- Per Business Quant data, the three most recent Income from Discontinued Operations figures were -$498000.0 in Q4 2020, -$995000.0 in Q1 2020, and $187000.0 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -498,000.00 |
| Mar 31, 2020 | -995,000.00 |
| Dec 31, 2019 | 187,000.00 |
| Jun 30, 2019 | 178,000.00 |
| Dec 31, 2018 | -1.02 Mn |
| Sep 30, 2018 | -904,000.00 |
| Jun 30, 2018 | -4.46 Mn |
| Mar 31, 2018 | -4.55 Mn |
| Dec 31, 2017 | -80.23 Mn |
| Sep 30, 2017 | 815,000.00 |
| Jun 30, 2017 | 1.82 Mn |
| Mar 31, 2017 | -1.96 Mn |
| Dec 31, 2016 | -23.49 Mn |
| Sep 30, 2016 | -8.00 Mn |
| Jun 30, 2016 | -3.78 Mn |
| Mar 31, 2016 | -29.39 Mn |
| Dec 31, 2015 | -14.89 Mn |